Cytek Biosciences Income Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.03B	0.04B	0.04B	0.04B	0.04B	0.05B	0.04B	0.05B	0.05B	0.06B	0.04B	0.05B	0.05B	0.06B	0.04B	0.05B	0.05B	0.06B	0.04B	0.05B
Cost of Revenue (Quarter)	0.01B	0.02B	0.01B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.03B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.02B	0.02B
Gross Profit (Quarter)	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.02B	0.03B	0.03B	0.03B	0.02B	0.03B	0.03B	0.03B	0.02B	0.02B	0.03B	0.03B	0.02B	0.03B
Operating items
Research & Development (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B
Other Operating Expenses (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Operating Expenses (Quarter)	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.03B	0.04B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.03B	0.04B	0.04B	0.04B	0.04B
Operating Income (Quarter)	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B
EBIT (Quarter)	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B
Non-operating items
Non Operating Investment Income (Quarter)						0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B
Interest & Investment Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B
Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B
Net income details
EBT (Quarter)	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.01B	-0.00B	0.00B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.02B	-0.01B
Tax Provisions (Quarter)	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.04B	0.00B	0.00B
Profit After Tax (Quarter)	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.00B	-0.04B	-0.02B	-0.01B
Income from Non-Controlling Interests (Quarter)		0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B			0.00B
Income from Continuing Operations (Quarter)	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	-0.04B	-0.02B	-0.01B
Consolidated Net Income (Quarter)	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	-0.04B	-0.02B	-0.01B
Income towards Parent Company (Quarter)	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	-0.04B	-0.02B	-0.01B
Preferred Dividend Payments (Quarter)	0.00B	-0.00B
Net Income towards Common Stockholders (Quarter)	0.00B		-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	-0.04B	-0.02B	-0.01B
Additional items
EPS (Basic) (Quarter)	0.00		-0.02	0.00	0.01	0.03	-0.05	-0.03	-0.05	0.04	-0.05	-0.08	0.01	0.07	-0.09	-0.04	-0.04	-0.35	-0.15	-0.09
EPS (Diluted) (Quarter)	0.00		-0.02	0.00	0.01	0.03	-0.05	-0.03	-0.05	0.04	-0.05	-0.08	0.01	0.07	-0.09	-0.04	-0.04	-0.35	-0.15	-0.09
Shares Outstanding (Quarter)	0.11B	0.08B	0.13B	0.13B	0.13B	0.13B	0.14B	0.14B	0.14B	0.14B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B
Shares Outstanding (Diluted) (Quarter)	0.11B	0.08B	0.13B	0.13B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B
Shares Outstanding (Entity) (Quarter)	0.11B	0.08B	0.13B	0.13B	0.13B	0.14B	0.14B	0.14B	0.14B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B	0.13B
EBITDA (Quarter)	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B
Interest Expenses (Quarter)	0.01B	0.00B	47.67B	45.35B	0.00B	0.00B	0.00B	0.02B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.04B	0.02B	0.02B	0.00B	0.02B	0.02B
Tax Rate (Quarter)	31.57%	362.39%	34.67%	49.89%	12.11%	9.63%	24.34%	33.36%	-54.27%	-33.86%	31.14%	-45.20%	-509.55%	6.97%	-1.21%	17.59%	29.60%	-992.26%	-8.63%	-4.42%

Research Tools

Datasets

Plans

Developers

Cytek Biosciences CTKB Income Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

Cytek Biosciences CTKB Income Statement (2020-2026)

Create an account

Sign In

Reset Password